Dentium CO., LTD (KRX:145720)

Market Cap	393.57B -35.5%
Revenue (ttm)	356.03B -13.9%
Net Income	42.11B -51.0%
EPS	4,882.41 -51.0%
Shares Out	7.81M
PE Ratio	10.32
Forward PE	9.02
Dividend	600.00 (1.36%)
Ex-Dividend Date	Mar 20, 2026

Volume	47,152
Average Volume	49,285
Open	50,000
Previous Close	50,400
Day's Range	48,150 - 50,400
52-Week Range	43,100 - 85,500
Beta	0.78
RSI	53.44
Earnings Date	Mar 13, 2026

About Dentium CO., LTD

Dentium CO., LTD manufactures and sells dental medical instrument worldwide. Its implant systems include superline, implantium, implantium 2, N.R. line, simple line 2, and slim line. The company also provides block and coloring; regeneration products; and digital dentistry products. In addition, it offers orthodontics, bright resin, tooth care, and other dental products. The company was formerly known as Biostech Co., Ltd. and changed its name to Dentium Co.,Ltd. in August 2002. Dentium Co.,Ltd. was founded in 2000 and is headquartered in Seoul...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2000
• Employees: 853
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 145720

Financial Performance

In 2024, Dentium CO., LTD's revenue was 407.81 billion, an increase of 3.72% compared to the previous year's 393.19 billion. Earnings were 72.71 billion, a decrease of -24.67%.